295 related articles for article (PubMed ID: 32479922)
1. NSAIDs in CKD: Are They Safe?
Baker M; Perazella MA
Am J Kidney Dis; 2020 Oct; 76(4):546-557. PubMed ID: 32479922
[TBL] [Abstract][Full Text] [Related]
2. Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
Zhan M; Doerfler RM; Xie D; Chen J; Chen HY; Diamantidis CJ; Rahman M; Ricardo AC; Sondheimer J; Strauss L; Wagner LA; Weir MR; Fink JC;
Am J Kidney Dis; 2020 Aug; 76(2):184-193. PubMed ID: 32317121
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Prescription Analgesic Use in Older Adults With and Without Chronic Kidney Disease and Outcomes.
Han Y; Balkrishnan R; Hirth RA; Hutton DW; He K; Steffick DE; Saran R
JAMA Netw Open; 2020 Sep; 3(9):e2016839. PubMed ID: 32997126
[TBL] [Abstract][Full Text] [Related]
4. The case for cautious consumption: NSAIDs in chronic kidney disease.
Sriperumbuduri S; Hiremath S
Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):163-170. PubMed ID: 30531470
[TBL] [Abstract][Full Text] [Related]
5. Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study.
Hsu CC; Wang H; Hsu YH; Chuang SY; Huang YW; Chang YK; Liu JS; Hsiung CA; Tsai HJ
Hypertension; 2015 Sep; 66(3):524-33. PubMed ID: 26169048
[TBL] [Abstract][Full Text] [Related]
6. Retrospective pharmacovigilance analysis of nonsteroidal anti-inflammatory drugs-induced chronic kidney disease.
Swathi VS; Saroha S; Prakash J; Bhushan S
Indian J Pharmacol; 2021; 53(3):192-197. PubMed ID: 34169903
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal Anti-inflammatory Drugs: Clinical Implications, Renal Impairment Risks, and AKI.
LaForge JM; Urso K; Day JM; Bourgeois CW; Ross MM; Ahmadzadeh S; Shekoohi S; Cornett EM; Kaye AM; Kaye AD
Adv Ther; 2023 May; 40(5):2082-2096. PubMed ID: 36947330
[TBL] [Abstract][Full Text] [Related]
8. Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease.
Chan KW; Smeijer JD; Schechter M; Jongs N; Vart P; Kohan DE; Gansevoort RT; Liew A; Tang SCW; Wanner C; de Zeeuw D; Heerspink HJL
Kidney Int; 2023 Dec; 104(6):1219-1226. PubMed ID: 37657768
[TBL] [Abstract][Full Text] [Related]
9. Renal toxicity of the nonsteroidal anti-inflammatory drugs.
Murray MD; Brater DC
Annu Rev Pharmacol Toxicol; 1993; 33():435-65. PubMed ID: 8494347
[TBL] [Abstract][Full Text] [Related]
10. Chronic pain and analgesic use in CKD: implications for patient safety.
Wu J; Ginsberg JS; Zhan M; Diamantidis CJ; Chen J; Woods C; Fink JC
Clin J Am Soc Nephrol; 2015 Mar; 10(3):435-42. PubMed ID: 25710806
[TBL] [Abstract][Full Text] [Related]
11. Can NSAIDs Be Used Safely for Analgesia in Patients with CKD?: COMMENTARY.
Baker ML; Perazella MA
Kidney360; 2020 Nov; 1(11):1192-1194. PubMed ID: 35372870
[No Abstract] [Full Text] [Related]
12. Analgesic use and associated adverse events in patients with chronic kidney disease: a systematic review and meta-analysis.
Lambourg E; Colvin L; Guthrie G; Walker H; Bell S
Br J Anaesth; 2022 Mar; 128(3):546-561. PubMed ID: 34763813
[TBL] [Abstract][Full Text] [Related]
13. Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population.
Modig S; Elmståhl S
Int J Clin Pharm; 2018 Aug; 40(4):870-877. PubMed ID: 29460083
[TBL] [Abstract][Full Text] [Related]
14. Specification, validation, and adherence of quality indicators to optimize the safe use of nonsteroidal anti-inflammatory drugs for knee osteoarthritis pain in the primary care setting.
Swan JT; Rizk E; Duong PY; Alghamdi BM; Kaur N; Nagaraj S; Brown AE; Flores E; Spence N; Tajchman S
BMC Musculoskelet Disord; 2023 Sep; 24(1):761. PubMed ID: 37759196
[TBL] [Abstract][Full Text] [Related]
15. Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD.
Zhan M; St Peter WL; Doerfler RM; Woods CM; Blumenthal JB; Diamantidis CJ; Hsu CY; Lash JP; Lustigova E; Mahone EB; Ojo AO; Slaven A; Strauss L; Taliercio JJ; Winkelmayer WC; Xie D; Fink JC;
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1778-1786. PubMed ID: 28811297
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort study.
Lipworth L; Abdel-Kader K; Morse J; Stewart TG; Kabagambe EK; Parr SK; Birdwell KA; Matheny ME; Hung AM; Blot WJ; Ikizler TA; Siew ED
BMC Nephrol; 2016 Nov; 17(1):189. PubMed ID: 27881100
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review.
Nderitu P; Doos L; Jones PW; Davies SJ; Kadam UT
Fam Pract; 2013 Jun; 30(3):247-55. PubMed ID: 23302818
[TBL] [Abstract][Full Text] [Related]
18. Burden of Renal Events Associated with Nonsteroidal Anti-inflammatory Drugs in Patients with Osteoarthritis and Chronic Low Back Pain: A Retrospective Database Study.
Katsuno T; Togo K; Ebata N; Fujii K; Yonemoto N; Abraham L; Kikuchi S
Pain Ther; 2021 Jun; 10(1):443-455. PubMed ID: 33439471
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study.
Abd ElHafeez S; Hegazy R; Naga Y; Wahdan I; Sallam S
J Egypt Public Health Assoc; 2019; 94(1):8. PubMed ID: 30799879
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease.
Heleniak Z; Cieplińska M; Szychliński T; Rychter D; Jagodzińska K; Kłos A; Kuźmiuk I; Tylicka MJ; Tylicki L; Rutkowski B; Dębska-Ślizień A
J Nephrol; 2017 Dec; 30(6):781-786. PubMed ID: 27679400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
